David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$365M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$307M |
| 3 |
Adobe
ADBE
|
+$250M |
| 4 |
NVIDIA
NVDA
|
+$242M |
| 5 |
Salesforce
CRM
|
+$240M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$520M |
| 2 |
ExxonMobil
XOM
|
+$372M |
| 3 |
Bank of America
BAC
|
+$271M |
| 4 |
Netflix
NFLX
|
+$172M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.15% |
| 2 | Financials | 9.51% |
| 3 | Healthcare | 7.52% |
| 4 | Consumer Discretionary | 6.79% |
| 5 | Communication Services | 5.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARIS
3976
DELISTED
Aris Water Solutions
ARIS
| $422K | ﹤0.01% |
33,076
-34,054
| -51% | -$582K |
|
3977
Live Nation Entertainment
LYV
$42.9B
| $422K | ﹤0.01% |
+5,551
| New | +$497K |
|
3978
Atlanta Braves Holdings Series B
BATRK
$3.33B
| $421K | ﹤0.01% |
15,320
-7,510
| -33% | -$205K |
|
3979
PUT
Baker Hughes
BKR
$61.7B
| $419K | ﹤0.01% |
20,000
| – | – |
|
3980
KT
KT
$9.31B
| $419K | ﹤0.01% |
34,303
-220,576
| -87% | -$3.04M |
|
3981
Adaptive Biotechnologies
ADPT
$4.16B
| $418K | ﹤0.01% |
58,684
-97,500
| -62% | -$918K |
|
|
FLNA
3982
CALL
Filana Therapeutics
FLNA
$44.3M
| $418K | ﹤0.01% |
10,000
| – | – |
|
3983
Cohu
COHU
$2.39B
| $417K | ﹤0.01% |
+16,172
| New | +$449K |
|
3984
Carvana
CVNA
$81.8B
| $417K | ﹤0.01% |
102,650
-1,353,450
| -93% | -$8.83M |
|
3985
Vishay Intertechnology
VSH
$4.71B
| $416K | ﹤0.01% |
23,394
-88,052
| -79% | -$1.72M |
|
3986
Vitamin Cottage Natural Grocers
NGVC
$647M
| $415K | ﹤0.01% |
38,448
-4,461
| -10% | -$66.2K |
|
3987
RLI Corp
RLI
$6B
| $415K | ﹤0.01% |
+8,106
| New | +$453K |
|
|
AAMI
3988
Acadian Asset Management
AAMI
$3.37B
| $415K | ﹤0.01% |
+27,838
| New | +$500K |
|
|
ZYNE
3989
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $415K | ﹤0.01% |
567,116
-542,039
| -49% | -$615K |
|
|
CAJ
3990
DELISTED
Canon, Inc.
CAJ
| $415K | ﹤0.01% |
19,041
-141,470
| -88% | -$3.33M |
|
|
PCSB
3991
DELISTED
PCSB Financial Corporation
PCSB
| $415K | ﹤0.01% |
23,160
+12,681
| +121% | +$242K |
|
3992
Alamos Gold
AGI
$15.9B
| $414K | ﹤0.01% |
55,913
-485,049
| -90% | -$3.59M |
|
|
CWAN
3993
DELISTED
Clearwater Analytics
CWAN
| $414K | ﹤0.01% |
24,657
-27,189
| -52% | -$397K |
|
3994
PUT
General Mills
GIS
$21.2B
| $414K | ﹤0.01% |
+5,400
| New | +$412K |
|
|
PFHD
3995
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
| $414K | ﹤0.01% |
+15,961
| New | +$407K |
|
3996
Lifecore Biomedical
LFCR
$175M
| $413K | ﹤0.01% |
46,403
-4,065
| -8% | -$41.3K |
|
|
NVEE
3997
DELISTED
NV5 Global
NVEE
| $413K | ﹤0.01% |
13,336
+936
| +8% | +$30.6K |
|
3998
Prospect Capital
PSEC
$1.19B
| $413K | ﹤0.01% |
66,544
-68,131
| -51% | -$509K |
|
|
CSR
3999
CALL
Centerspace
CSR
$901M
| $411K | ﹤0.01% |
+6,100
| New | +$484K |
|
4000
Nature's Sunshine
NATR
$253M
| $411K | ﹤0.01% |
49,930
+5,722
| +13% | +$56.8K |
|
Similar funds
David Shaw's Q3 2022 Portfolio in Review
As of Q3 2022, David Shaw held 5,820 positions worth $83.7B, down 1.8% from $85.3B the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.
David Shaw withdrew a net $3.66B in Q3 2022, closing 678 positions and reducing 1,597 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $171M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
Against the trend, David Shaw opened a new position in Prologis worth $66.1M.
- David Shaw's largest Q3 2022 buy was Prologis: 650,725 shares worth $66.1M.
- David Shaw added most to Visa in Q3 2022, an estimated $365M increase.
- David Shaw's biggest Q3 2022 reduction was PayPal, cutting an estimated $520M.
- David Shaw fully exited iShares MSCI Emerging Markets ETF in Q3 2022, selling an estimated $171M.
- David Shaw's ten largest holdings make up 8.7% of its $83.7B portfolio in Q3 2022.
- David Shaw opened 545 new positions and closed 678 in Q3 2022.
- David Shaw's portfolio value fell 1.8% quarter-over-quarter to $83.7B.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.